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Abstract
Objective—To report the results of cochlear implant-elicited cortical auditory evoked potentials
(eCAEP) in children with cochlear nerve deficiency (CND).
Study Design—Case control series.
Setting—Tertiary academic referral center.
Patients—Seven children with CND that have a cochlear implant in their affected ear. Four
children without CND served as controls.
Intervention(s)—eCAEPs were elicited by activation of individual cochlear implant electrodes.
Main Outcome Measure(s)—Onset responses (P1-N1-P2 complex).
Results—Three of 7 CND children demonstrated eCAEP responses across a broad range of
electrodes despite having limited or no open set speech perception abilities using their implants.
Two of these children had eCAEPs that were characterized by substantial variability in latency,
amplitude, and number of electrodes with identifiable responses. The remaining 4 ears with CND
and poor speech perception had multiphasic responses that are inconsistent with eCAEPs. Non-
CND ears with excellent speech perception abilities demonstrated robust responses on all
electrodes stimulated.
Conclusions—Abent eCAEP responses were indicative of poor open-set speech perception
skills in all cases. However, eCAEP onset responses were measurable in some children with
imaging evidence of CND, indicating probable cochlear nerve hypoplasia rather than aplasia. That
some children with CND and poor speech perception had robust eCAEPs in some instances makes
this particular measure of limited utility for predicting good speech perception outcomes following
cochlear implantation in these children. The origin of multiphasic responses remains to be
determined but may be of somatosensory origin in some instances.
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INTRODUCTION
Cochlear implants provide sound awareness and speech understanding for hearing-impaired
individuals. Improved access to previously inaudible sound enhances spoken language
acquisition for pre-linguistic children and restores communication for post-linguistic
children and adults (1,2). The benefits of this intervention are far-reaching. Cochlear
implants enhance educational and employment opportunities and achievement, socialization
with alleviation of isolation and depression, and overall quality of life (3,4).
The only absolute contraindication to cochlear implantation is an absent cochlea or cochlear
nerve. In such instances, the multiple electrode array lacks the necessary neural interface for
discrete auditory stimulation. While the diagnosis of cochlear aplasia (i.e. Michel) is readily
apparent on imaging studies, cochlear nerve aplasia or hypoplasia is decidedly more
challenging to diagnose, owing to the limits of spatial resolution in currently available
modalities. Because of this uncertainty in diagnosis, the term cochlear nerve deficiency
(CND) was coined to refer to the situation where the cochlear nerve or its osseous conduit is
not visible on imaging (5-7). The clinical diagnosis of CND includes these imaging findings
in the setting of profound hearing loss. Auditory brainstem response testing that shows a
present cochlear microphonic but absent neural waves can support the diagnosis (8).
An absent internal auditory canal (IAC) on either high-resolution computed tomography
(CT) or magnetic resonance imaging (MRI) is clear evidence for cochlear nerve aplasia.
When the IAC is narrow (<3 mm), an absent cochlear nerve aperture or bony cochlear nerve
canal (BCNC) also provides good evidence for CND. In the setting of a normal dimension
IAC, MRI can usually resolve a normal cochlear nerve; however, a very small or absent
nerve might have a similar appearance (5-7).
Because of this diagnostic uncertainty in cochlear nerve imaging, cochlear implantation has
been undertaken in a number of children with CND (9-12). Results of these interventions
suggest that most children with CND gain some sound awareness from their device using
higher levels of electrical stimulation. However, achievement of open set speech perception
for the purposes of speech and language development has been largely unsuccessful,
probably as a result of a poor electrode-neural interface and other associated conditions. In
one study, only 19% of children with CND developed any open set speech perception using
their cochlear implant, and none of these children were able to communicate using auditory-
only information (i.e. all used some supplemental sign language) (9).
Bilateral CND in children is often times only one manifestation of a larger syndromic
etiology such as CHARGE, VATER, or congenital hydrocephalus, among others. In such
instances, the lack of developmental progress with a cochlear implant might as easily be
attributable to associated learning disabilities rather than the anatomic cochlear nerve issue.
In an effort to distinguish auditory from non-auditory activation in implanted children with
CND, previous studies have used electrically evoked compound action potential (ECAP)
and brainstem response (EABR) testing (9,10,13,14). The results of these studies
demonstrate limited or no ECAPs in CND children. In rare instances, EABR testing
demonstrates normal wave Vs but more commonly it reveals abnormal peaks with atypical
latencies and morphologies or no reliable waves are evident on such testing (10, 13, 14).
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The cortical auditory evoked potential (CAEP) is a cortically generated potential that
provides information about the integrity of the auditory system and the neural processing of
sound beyond the auditory brainstem. It can be recorded using a passive listening paradigm
using an acoustic or electric stimulus. In the latter case it is referred to as the electrically
evoked CAEP (eCAEP). In normal-hearing adults, the CAEP consists of a series of peaks
(P1, N1, P2) occurring within a time window of 50-250 ms after stimulus onset. Responses
from normal-hearing children less than 5 years of age show only a large, broad P1 (around
100 ms) followed by the N2 component (15,16). The emergence of the P1-N1-P2 complex
occurs by 9-12 years of age (17). In cochlear implant children, the eCAEP can be reliably
recorded in response to sound field stimuli transduced by the implant's speech processor or
by electrical pulse trains delivered directly to specific implant electrodes (18-21). In early-
implanted children who have extensive listening experience with their devices, eCAEPs are
of a similar morphology to those of age-matched peers with normal hearing. Children
implanted at older ages may not show age-dependent changes in the eCAEP (18).
There are sparse data on eCAEPs in children with well-defined CND. Such data are
important for at least two reasons. First, information concerning auditory evoked cortical
activity might be of significance to decisions concerning recommended communication
strategies for these children and their families. Second, there is a growing interest in the
possibility of auditory brainstem implantation as an intervention option in CND children
who do not benefit from cochlear implantation. Knowledge of cochlear-implant evoked
cortical activity may contribute to an informative index of benefit. The purpose of this study
therefore is to measure eCAEPs in a group of children with well-defined CND and who have
significant device experience such that their outcome performance is known and stable.
MATERIALS AND METHODS
Subjects
The biomedical institutional review board (IRB) approved this study. The procedures
followed were in accordance with the ethical standards of the IRB and with the Helsinki
Declaration. All subjects signed an approved informed consent and were paid for their
participation.
Seven implanted CND children (3 to 15 yrs) and 3 implanted non-CND children (5 to 12
yrs) participated in the study. Demographic information, inner ear malformation type, age at
implantation, duration of use, electrode array and presence/absence of ECAPs for these
patients are listed in Table 1. The diagnosis of CND was made preoperatively in all but one
child (CND6) according to previously reported diagnostic imaging protocols (5-8). The
details regarding cochlear implant outcomes and the utility of ECAPs in these children were
reported as a part of a larger study previously (9). CND6 had unilateral CND (right) and
bilateral cochlear implants. Sensorineural hearing loss (SNHL) children with normal
cochlear nerves who were roughly age-matched to the CND children with speech perception
abilities served as controls. All patients were using Cochlear Corporation devices
(Englewood, CO) in their test ear. Data from both ears (left non-CND, right CND) of CND6
are reported in this study.
General Procedure
The experimental protocol included aided (i.e. cochlear implant) pure-tone thresholds and
aided speech perception measures (Table 2). All of these tests were carried out on the same
day.
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Behavioral Audiometry and Speech Perception Testing—During programming
sessions, observation and conditioned behavioral audiometry techniques were used to
determine electrical thresholds and comfortable listening levels. When stimulation levels
resulted in visible or painful facial contractions, higher levels were generally not attempted.
After device fitting, speech perception assessment was attempted with children at 6-month
intervals when possible. Standard tests included a hierarchical battery of measures as
previously described (9). For this study, the results of the open-set, Phonetically Balanced
Kindergarten word lists (PBK words) are shown. Tests were administered in a sound
controlled environment using live-voice or recorded stimuli presented at 60 dB SPL. Due to
age and attention restrictions, it was generally necessary to use live voice presentations for
younger children to complete the tests.
Electrophysiological Tests
Stimuli: The stimuli to elicit the eCAEP were created using custom-designed software
incorporating Nucleus Implant Communicator (NIC) programming routines. Electrical
stimulation was delivered to individual electrodes by way of the NIC interface. The software
also generated a trigger pulse coincident with the onset of the stimulus pulse train that was
used to synchronize the stimulating and recording systems.
The stimulus was a 100-ms train of biphasic pulses with an inter-stimulation interval of 900
ms delivered in the monopolar mode (MP1). The stimulating electrodes, pulse widths, inter
pulse gaps and rates were selected based on programming MAPs of individual patients.
These stimulating parameters used for each patient are listed in Table 3. Stimulation levels
were set at the maximum comfortable level measured for individual electrodes for each
patient, and held constant throughout the entire stimulation period.
Recording Procedure: Patients were tested in a single-walled sound booth. CND7 was
tested while seated on his parent's lap due to his young age. All others were seated in a
reclining chair and watched a silent movie with captions or played computer games on an
iPad 2® (Apple Corp, Cupertino, CA). They were instructed to ignore the stimulus and relax
but not fall asleep. Breaks were provided as needed. Each recording session took
approximately 2 hours.
Electroencephalographic (EEG) activity was recorded using an Intelligent Hearing System
SmartEP (Miami, FL) for CND6 and a Compumedics Neuroscan® (Charlotte, NC) for all
other patients. Disposable, sterile Ag-AgCl surface electrodes were used to record the EEG.
Responses were differentially recorded between electrodes positioned at Fz (positive) and
contralateral mastoid (reference). A ground electrode was placed on the low forehead (Fpz).
Eye-blink activity was monitored using two recording electrodes placed superior and
inferior to the eye contralateral to the implant ear. Ocular artifacts exceeding ±100 μV were
rejected from averaging. Electrode impedances were maintained below 5000 Ohms with an
inter-electrode impedance difference of less than 2000 Ohms. The recording window
consisted of a 100-ms pre-stimulus baseline and a 412-ms peri/post-stimulus time for CND6.
For all other patients, the recording window included a 100-ms pre-stimulus baseline and a
600-ms peri/post-stimulus time. For CND6, responses were amplified with a gain of 10k,
analog filtered online between (1-100 Hz), and sampled at a rate of 1000 Hz. For all other
patients, responses were amplified (10× gain), analog filtered online between 0.1 and 100
Hz (24 dB/octave roll-off) prior to averaging, and sampled at a rate of 1000 Hz. After eye-
blink rejection, the remaining (at least 200) sweeps per stimulating electrode were averaged
and digitally filtered between 1-30 Hz (24 dB/octave) offline using custom-designed
MATLAB software. Averaged responses were smoothed using a 40-msec wide boxcar filter
before response identification and amplitude measurements.
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Electrophysiological responses were independently assessed by two experienced observers.
Visual identification of the eCAEPs was based on peak latency and waveform morphology.
The presence/absence of each response was determined on the basis of mutual agreement
between these two researchers. For each patient, peak amplitude and latency were measured
for each identifiable component of the eCAEP that was recorded from different electrodes.
Peak latency was measured at the most positive or negative point and peak amplitude was
measured from baseline to peak.
RESULTS
Table 1 details patient demographics, inner ear morphology, electrode array, and ECAP
status for the implanted ear. Five CND children had inner ear malformations characterized
as hypoplastic spectrum, one had a common cavity, and one had normal morphology. One
child (CND6) had a CND ear (implanted first) and a non-CND ear (implanted second) and
thus is represented in both CND and non-CND data sets. Mean (SD) age at implantation,
duration of device use, and age at testing was 4.5 (2.8), 5.7 (2.9), and 10.2 (4.5) yrs. in the
CND ears and 3.9 (2.5), 5.7 (1.4), and 9.6 (3.0) yrs. in the non-CND ears. Only 2 (28.6%) of
7 ears with CND had present ECAPs while all 4 ears without CND had present responses.
Pure tone thresholds, speech awareness thresholds (SAT), PBK word and phoneme scores
from all subjects are listed in Table 2. All patients had sound detection across the various
frequencies. CND patients tended to have higher pure tone thresholds than non-CND
patients. However, mean (SD) SAT was 21.4 dB (12.8) for the CND ears and 12.5 dB (5.0)
for the non-CND ears. Three CND ears (CND1, CND2, CND3) had limited open set speech
perception (mean PBK word 27%, range 16-36%; mean PBK phoneme 62%, range 45-72%)
while the remaining 4 CND ears had 0% PBK word and phoneme scores. By contrast, the
mean PBK word and phoneme scores for the 4 non-CND ears were 91.5% (3.4) and 96.3%
(1.3), respectively.
Figure 1 shows the eCAEPs recorded from non-CND ears for reference with the respective
speech perception measures. In general, all electrodes tested had robust eCAEP responses
within the 100-250 ms epoch, with age-appropriate waveform morphologies. Within this
group, the oldest child (SNHL2) demonstrated a very well formed P1-N1-P2 complex.
Responses recorded from two other children are dominated by P1 components. Figures 2
and 3 show the responses and PBK word results for the CND ears with and without
identifiable responses, respectively. While the responses of CND2 look very similar to those
recorded from the non-CND ears, the onset responses for CND1 and CND4 are
characterized by substantial variability in latency and amplitude across the electrodes tested.
For instance, responses recorded for e11, e12, e13, e16, e19 and e22 from CND1 are
dominated by a P1 component followed by an N2 peak similar to those recorded from
SNHL1, a child with a comparable age of implantation and duration of use. However, the
most basal electrode tested (e10) in CND1 shows a multi-peaked morphology with none of
the peaks matching expected eCAEP latencies. CND4 also showed robust onset responses
on many electrodes with a similar multi-peaked response on the basal electrode e3. Peak
amplitudes and latencies of the eCAEP measured for these children are listed in Table 4.
For CND3, responses recorded from all electrodes exhibited multiphasic morphologies,
which are inconsistent with a typical eCAEP response. Specifically, responses recorded
from stimulation of e11 and e13 consisted of two positive peaks and two negative peaks.
The first positive peak occurred around 100 ms and the second positive peak had a latency
of 250 ms. The latency for the first and the second negative peak was 200 and 350 ms,
respectively. Consistent morphology was observed for responses recorded for e16, e19 and
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e22. However, these responses did not exhibit any waveform peak latencies or morphology
that would be expected for a typical eCAEP.
Figure 3 shows the recorded responses from 3 CND ears (CND5, CND6, CND7) without
any measurable speech perception. These responses do not show morphological
characteristics of typical eCAEPs. No replicable peaks can be identified in any of these
recording traces.
Figure 4 shows responses recorded from CND6, a child with unilateral CND (right ear) and
bilateral implants. Recordings from the left ear demonstrate the expected P1-N1 morphology
similar to that seen in other non-CND, good performing ears. By contrast, responses elicited
from stimulation of the poor performing CND ear (right) in panel (b) appear multiphasic
with symmetric, positive-negative characteristics. These responses also start concurrently
with the stimulus onset. Importantly, this child claimed to “feel” stimulation in the CND
(right) ear and “hear” the stimulation in the left ear. The child experienced no dizziness or
facial twitching during stimulation.
DISCUSSION
Synchronous and discrete activation of the auditory system through electrical stimulation is,
in part, a necessary precondition for effective cochlear implant use. Such activation requires
well-positioned intracochlear electrodes and sufficient neural substrate. In children with
congenital hearing loss, neural integrity is determined prior to implantation through
assessments of residual hearing (auditory brainstem response and behavioral testing) and
imaging (MRI and/or CT). Following implantation, neural integrity is assumed when
behavioral responses to electrode activation occur at low charge levels, robust implant-
evoked electrophysiological responses are evident on ECAP testing and speech perception
and language develop at expected rates. When performance is less than expected, there are
limited tools available for truly objective assessment.
CND on high-resolution imaging is a poor prognostic sign for the development of open set
speech perception using a cochlear implant (9-11). Most children with CND can however,
show some degree of sound awareness with their implants using higher than normal charge
levels for stimulation. These responses, in theory, can be related to auditory stimulation of
residual cochlear nerve fibers that are not resolvable on imaging or to non-auditory
stimulation (vestibular, somatosensory, or motor). The present study is a preliminary work
to compare eCAEPs in implanted children with and without evidence of CND in an effort to
better understand auditory system activation in CND children.
Implanted children without CND exhibited robust eCAEP onset responses (P1-N1-P2)
across a wide range of stimulated electrodes (basal→apical). CND children demonstrated
either good (CND2), absent (CND5-7) or mixed (CND1, CND4) onset responses to varying
degrees and locations of electrode stimulation. Three children (CND1 CND2, CND4) that
demonstrated good morphology onset response complexes across a broad range of
electrodes had limited or no open set speech perception using their implants. These results
imply that cochlear nerve aplasia is highly unlikely in this group of children. That CND1
had robust response ECAPs and some open set perception suggests that synchronizable
neural responses were inducible from the distal cochlear nerve and the auditory cortex. For
this child, the diagnosis of CND might be questionable except that the child's performance is
far less than expected despite having good therapy and cognitive abilities. For CND1,
CND2, CND4, varying degrees of cochlear nerve hypoplasia might explain their relative
poor performance even with present eCAEPs. Considering the fact that CND1 and CND4
had variable onset responses on some electrodes but not on others might support the premise
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that regional differences in neural populations exist. This finding might be consistent with a
hypoplastic nerve.
Results of this study demonstrate that children with CND and absent eCAEPs fail to achieve
open-set speech perception skills with their implant. However, children with robust eCAEP
onset responses are also not good performers. Thus, while an absent eCAEP is a clear sign
for poor performance, present or even robust responses are less predictive. These finding are
noteworthy and in contrast to previous investigations that used sound field activation of the
speech processor to evoke cortical responses. These differences might be related to
differences in the stimulation paradigm. One advantage of the set up used in the present
study is that individual electrodes can be stimulated, allowing regional differences in
intracochlear neural populations to be explored. Future studies, using a greater number of
stimulation sites might be needed to better decipher the relevance of these regional
stimulation differences.
Results of this study also suggest that electrically evoked compound action potentials
(ECAPs) do not provide predictive information about electrically evoked neural activation in
these CND children. For example, the ECAP could not be recorded from CND 2 and CND4.
However, robust eCAEP responses were recorded from some, if not all, electrodes in these
two patients. In contrast, for CND3, robust ECAP responses with normal morphologies,
amplitudes, and latencies were recorded from the same set of electrodes that were used for
the eCAEP recordings. Amplitude growth functions of the ECAP recorded from electrode
19 and 22 showed characteristics that were comparable to those described for SNHL
children (22). However, cortical responses recorded from this patient failed to show
characteristics of a typical eCAEP response. These findings in CND3 could be caused by
concurrent lesions in the central auditory system. Nevertheless, the possibility that the neural
generators of the “ECAP” recorded from this patient are located in vestibular system instead
of auditory system could not be excluded (23).
The source of multiphasic responses observed in 4 CND ears remains to be determined.
Options might include vestibular, somatosensory, or facial myogenic responses. That subject
CND6 described a non-auditory “feeling” during electrode activation that did not induce
dizziness, rotation, visual disturbance, facial contraction or twitching suggests a
somatosensory origin.
Overall, our results clearly indicate that the eCAEP onset response cannot be used as the
sole criteria for predicting good cochlear implant performance in CND children. The ability
to understand speech depends on how well the auditory system can detect incoming signals
(auditory detection) and discriminate differences among varying signals (auditory
discrimination). The CAEP evoked by a brief acoustic/electrical stimulus only provides
information about the neural encoding of the physical characteristics of sound that allows for
auditory detection. It does not appear to provide information about the necessary neural
processing that underlies auditory discrimination (24). Future work should focus on
identifying electrophysiologic predictors of auditory discrimination as these measures will
help families of children with CND (and other poor prognostic factors) make
communication choices such as the need for supplementary sign language or whether to
consider auditory brainstem implantation in lieu of their cochlear implant.
Acknowledgments
Supported, in part, by grants (to C.A.B.) from the Deafness Research Foundation (DRF) and the National Institutes
of Health (DC011383). The authors would like to thank Holly Teagle, Pat Roush, Corrine Macpherson, Sarah
Martinho, Nicelle Franco, Deb Hatch, Lisa Park, and Jennifer Woodard for the expert care of these children and
He et al. Page 7













their logistical assistance in carrying out these studies. We also wish to thank Carolyn Brown and Paul Abbas for
generously providing the stimulus software and Harold C. Pillsbury for his unwavering support of this work.
Supported, in part, by grants (to C.A.B.) from the Deafness Research Foundation (DRF) and the National Institutes
of Health (R21DC011383-01A1).
REFERENCES
1. Bassim MK, Buss E, Clark MS, et al. MED-EL Combi40+ cochlear implantation in adults.
Laryngoscope. 2005; 115:1568–73. [PubMed: 16148696]
2. Niparko JK, Tobey EA, Thal DJ, et al. Spoken language development in children following cochlear
implantation. JAMA. 2010; 21303:1498–506. [PubMed: 20407059]
3. Barton GR, Stacey PC, Fortnum HM, et al. Hearing-impaired children in the United Kingdom, IV:
cost-effectiveness of pediatric cochlear implantation. Ear Hear. 2006; 27:575–88. [PubMed:
16957506]
4. Francis HW, Chee N, Yeagle J, et al. Impact of cochlear implants on the functional health status of
older adults. Laryngoscope. 2002; 112:1482–8. [PubMed: 12172266]
5. Glastonbury CM, Davidson HC, Harnsberger HR, et al. Imaging findings of cochlear nerve
deficiency. AJNR Am J Neuroradiol. 2002; 23:635–43. [PubMed: 11950658]
6. Adunka OF, Roush PA, Teagle HF, et al. Internal auditory canal morphology in children with
cochlear nerve deficiency. Otol Neurotol. 2006; 27:793–801. [PubMed: 16936566]
7. Adunka OF, Jewells V, Buchman CA. Value of computed tomography in the evaluation of children
with cochlear nerve deficiency. Otol Neurotol. 2007; 28:597–604. [PubMed: 17667769]
8. Buchman CA, Roush PA, Teagle HF, et al. Auditory neuropathy characteristics in children with
cochlear nerve deficiency. Ear Hear. 2006; 27:399–408. [PubMed: 16825889]
9. Buchman CA, Teagle HF, Roush PA, et al. Cochlear implantation in children with labyrinthine
anomalies and cochlear nerve deficiency: implications for auditory brainstem implantation.
Laryngoscope. 2011; 121:1979–88. [PubMed: 22024855]
10. Valero J, Blaser S, Papsin BC, et al. Electrophysiologic and behavioral outcomes of cochlear
implantation in children with auditory nerve hypoplasia. Ear Hear. 2012; 33:3–18. [PubMed:
21750462]
11. Kutz JW Jr, Lee KH, Isaacson B, et al. Cochlear implantation in children with cochlear nerve
absence or deficiency. Otol Neurotol. 2011; 32:956–61. [PubMed: 21659925]
12. Warren FM 3rd, Wiggins RH 3rd, Pitt C, et al. Apparent cochlear nerve aplasia: to implant or not
to implant? Otol Neurotol. 2010; 31:1088–94. [PubMed: 20634773]
13. Walton J, Gibson WP, Sanli H, et al. Predicting cochlear implant outcomes in children with
auditory neuropathy. Otol Neurotol. 2008; 29:302–9. [PubMed: 18317399]
14. Song MH, Bae MR, Kim HN, et al. Value to intracochlear electrically evoked auditory brainstem
response after cochlear implantation in patients with narrow internal auditory canal.
Laryngoscope. 2010; 120:1625–31. [PubMed: 20564653]
15. Ponton CW, Eggermont JJ, Kwong B, et al. Maturation of human central auditory system activity:
evidence from multi-channel evoked potentials. Clin Neurophysiol. 2000; 111:220–36. [PubMed:
10680557]
16. Wunderlich JL, Cone-Wesson BK, Shepherd R. Maturation of the cortical auditory evoked
potential in infants and young children. Hear Res. 2006; 212:185–202. [PubMed: 16459037]
17. Ponton CW, Eggermont JJ, Khosla D, et al. Maturation of human central auditory system activity:
separating auditory evoked potentials by dipole modeling. Clin Neurophysiol. 2002; 113:407–20.
[PubMed: 11897541]
18. Sharma A, Dorman MF, Spahr AJ. A sensitive period for the development of the central auditory
system in children with cochlear implant: implications for age of implantation. Ear Hear. 2002;
23:532–9. [PubMed: 12476090]
19. Ponton CW, Eggermont JJ. Of kittens and kids: altered cortical maturation following profound
deafness and cochlear implant use. Audiol Neurootol. 2001; 6:363–80. [PubMed: 11847464]
He et al. Page 8













20. Gordon KA, Tanaka S, Wong DDE, Papsin BC. Characterizing responses from auditory cortex in
young people with several years of cochlear implant experience. Clin Neurophysiol. 2008;
119:2347–62. [PubMed: 18752993]
21. Gordon KA, Tanaka S, Wong DDE, Stockley T, Ramsden JD, Brown T, Jewell S, Papsin BC.
Multiple effects of childhood deafness on cortical activity in children receiving bilateral cochlear
implants simultaneously. Clin Neurophysiol. 2011; 122:823–33. [PubMed: 21094084]
22. Brown CJ, Abbas PJ, Etler CP, O'Brient S, Oleson JJ. Effects of long-term use of a cochlear
implant on the electrically evoked compound action potential. J Am Acad Audiol. 2010; 21:5–15.
[PubMed: 20085195]
23. Nie K, Bierer SM, Ling L, Oxford T, Rubinstein JT, Phillips JO. Characterization of the
electrically evoked compound action potential of the vestibular nerve. Otol Neurotol. 2011; 32:88–
97. [PubMed: 21192375]
24. Martin BA, Tremblay KL, Korczak P. Speech evoked potentials: from the laboratory to the clinic.
Ear Hear. 2008; 29:285–313. [PubMed: 18453883]
He et al. Page 9














The eCAEPs recorded from non-CND ears
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Neural responses recorded from four CND ears.
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Traces without any identifiable neural responses recorded from three CND ears.
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Responses recorded from CND6.
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